Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News on Pharma

FTSE 100 chief executive average pay jumps by 39% to £3.4m

“To see CEO pay rocketing to more than 100 times the average salary is sickening,” say union bosses

The Independent UK

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives

The Independent UK

Fentanyl seizure: experts warn potent drug could rapidly emerge as a problem in Australia

Experts say news of record haul of more than 11kg of the opioid drug, found in February, should have been announced sooner

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

Why are federal authorities so concerned about a record fentanyl shipment found in Melbourne?

After a record amount of fentanyl was seized in Melbourne, authorities are sounding the alarm about the highly dangerous drug that has rarely been found in Australia.

ABC News

AFP, ABF discover record fentanyl seizure in machinery sent from Canada to Melbourne

Federal authorities have intercepted a record amount of the potentially deadly opioid fentanyl, hidden inside machinery sent to Melbourne.

ABC News

Govt frets over Rohypnol sales

The government has ordered authorities to sweep out manufacturers and vendors who illegally produce or sell Rohypnol, aka the blue tongue pill, to curb abuse of the drug among teenagers.

Bangkok Post

Outreach programme for pharma industries held

HYDERABAD

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Pharma funds Illinois pols, ‘Sister Jean’ turns 103, Honest Chicagoans talk Air and Water Show and more in your Chicago news roundup

Today’s update is a 5-minute read that will brief you on the day’s biggest stories.

Chicago Sun-Times

Hearing aids OK’d for over-the-counter sale starting in October, prices expected to fall

The Food and Drug Administration said the new regulation creates a new class of hearing aids that don’t require a medical exam or prescription. They’ll be sold online or over-the-counter at pharmacies and other stores.

Chicago Sun-Times

EU backs changing monkeypox vaccine injection method to boost supply

European countries could stretch out limited supplies of the monkeypox vaccine by administering smaller doses of the shot, the European Medicines Agency (EMA) said on Friday.

Reuters

EU regulator OKs plan to increase monkeypox vaccine supplies

The European Medicines Agency said a smaller dose of the monkeypox vaccine appears to still be effective and can be used to stretch the current supply by five times, echoing a recommendation made earlier this month by the U.S. Food and Drug Administration

The Independent UK

Illinois Senate President Don Harmon, other pols keep taking money from pharma companies implicated in opioid crisis

The Oak Park Democrat continues to accept campaign money from Johnson & Johnson, 1 of 4 companies paying $26 billion to settle suits accusing them of fueling the crisis. He’s not the only Illinois official doing so.

Chicago Sun-Times

Drug trade thrives in darknet

Drug traffickers have gone hi-tech and are using dark web, social media and crypto currency to carry on their activities clandestinely, reveals a police investigation following a drug bust

The Hindu

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA) for its lead candidate B-VEC in the treatment of patients with dystrophic epidermolysis bullosa (DEB). The regulatory agency has granted Priority Review designation and assigned a target actin date of February 17,…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Awakn's Second Licensing Partnership Agreement In A Week, This Time In Canada: Ketamine For Pain Comorbidities

Psychedelics therapeutics biotech company Awakn Life Sciences Corp. (OTCQB: AWKNF) has signed what constitutes its first licensing partnership deal in Canada.

Benzinga

Clinical Grade 'LaNeo' MDMA Completes Release Testing And Is Ready For Export In Several Dosages

PharmAla Biotech Holdings Inc, the biotech company producing MDXX class molecules has released a large-scale batch of its proprietary MDMA API, “Laneo,” becoming the first publicly-traded venture to produce the drug within Good Manufacturing Processes (GMP) in such a major amount.

StockNews.com

1 Stock You Shouldn't Sell No Matter What

Renowned biopharmaceutical company AbbVie (ABBV) continued its business momentum in the second quarter with considerable progress for its new products and indications. Moreover, the company is well-positioned to benefit from significant advances across its pipeline. Given its diversified business model, strong financials, high profitability, discounted valuation, and solid growth prospects,…

StockNews.com

2 Pharma Stocks to Keep Your Portfolio Healthy This Fall

Despite the market volatility and odds of a recession, the pharma industry is well-positioned to grow due to the aging global population and the increasing chronic diseases. Therefore, investing in quality pharma stocks Pfizer (PFE) and Merck & Co. (MRK) could be wise. Read more.

Get all your
news in one place.

100's of premium titles.
One news app.

The Hindu

Supreme Court hears plea to monitor drug pricing

Petitioner cites case of Dolo 650, says any dosage beyond 500 mg is outside regulation

Benzinga

Jazz' Epidiolex, The Only FDA-Approved CBD Drug, Enters Phase 3 Trial Evaluating Its Effects In Patients With Myoclonic-Atonic Seizures

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has initiated a new Phase 3 trial to investigate the efficacy and safety of Epidiolex (cannabidiol), known as Epidyolex in Europe, in children and adolescents with e

The Philadelphia Inquirer

Endo, a PA opioid maker, files for bankruptcy with billions in debt

Endo International, one of the nation's larger opioid makers and with U.S. headquarters in Malvern, filed for bankruptcy protection in Manhattan on Tuesday, beset by $9.5 billion in total debt and threatened by thousands of opioid lawsuits.

Benzinga

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Benzinga

Hypocrisy All Around: Pfizer, NFL Are Hidden Sponsors Of Anti-Drug Group Fighting Against Cannabis Legalization

The Community Anti-Drug Coalitions of America (CADCA), which is fighting against federal cannabis legalization, recently removed a page on its website disclosing its partners.

Salon

Ron Johnson goes to bat for Big Pharma

Johnson worried that bill allowing Medicare to negotiate costs is "punishing the pharmaceutical industry"

1 … 135 136 137 138

People

Tedros Adhanom Ghebreyesus

Traisuree Taisaranakul

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.